| |
Latest 10 SEC filings (by transaction date) for CERO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 27/24 | Mar 25/24 | Rolfe Lindsey | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 112,500 | |
Mar 27/24 | Mar 25/24 | Rapaport Robyn | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 112,500 | |
Mar 27/24 | Mar 25/24 | Laporte Kathleen | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 112,500 | |
Mar 27/24 | Mar 25/24 | Ehrlich Christopher B | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 572,182 | |
Mar 27/24 | Mar 25/24 | Corey Daniel | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 856,671 | |
Mar 27/24 | Mar 25/24 | Carter Charles Ross | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 395,387 | |
Mar 27/24 | Mar 25/24 | Byrnes Michael | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 112,500 | |
Mar 27/24 | Mar 25/24 | Atwood Brian G | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 1,317,956 | |
Feb 26/24 | Feb 26/24 | Corey Daniel | Direct Ownership | Series A Convertible Preferred Stock | Form 3/A : Amendment of a previous Form 3 | ||
Feb 26/24 | Feb 26/24 | Corey Daniel | Indirect Ownership | Common Stock | Form 3/A : Amendment of a previous Form 3 | ||
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for CERO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 27/24 | Mar 25/24 | Rolfe Lindsey | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 112,500 | |
Mar 27/24 | Mar 25/24 | Rapaport Robyn | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 112,500 | |
Mar 27/24 | Mar 25/24 | Laporte Kathleen | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 112,500 | |
Mar 27/24 | Mar 25/24 | Ehrlich Christopher B | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 572,182 | |
Mar 27/24 | Mar 25/24 | Corey Daniel | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 856,671 | |
Mar 27/24 | Mar 25/24 | Carter Charles Ross | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 395,387 | |
Mar 27/24 | Mar 25/24 | Byrnes Michael | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 112,500 | |
Mar 27/24 | Mar 25/24 | Atwood Brian G | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 1,317,956 | |
Mar 11/24 | Feb 14/24 | Atwood Brian G | Indirect Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 13,857 | |
Mar 11/24 | Feb 14/24 | Atwood Brian G | Indirect Ownership | Series A Convertible Preferred Stock | A - Grant, award or other under Rule 16b-3(d) | 1,002 | $1,000.00 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |